CONTI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 5.754
EU - Europa 5.207
AS - Asia 2.016
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 12
SA - Sud America 6
OC - Oceania 5
Totale 13.018
Nazione #
US - Stati Uniti d'America 5.596
CN - Cina 1.750
IE - Irlanda 1.072
UA - Ucraina 844
DE - Germania 823
SE - Svezia 817
FI - Finlandia 749
IT - Italia 547
TR - Turchia 160
CA - Canada 155
AT - Austria 149
GB - Regno Unito 87
SG - Singapore 60
BE - Belgio 36
IN - India 21
NL - Olanda 18
FR - Francia 17
ES - Italia 14
EU - Europa 12
CZ - Repubblica Ceca 10
EG - Egitto 8
IL - Israele 7
ID - Indonesia 6
BJ - Benin 5
BR - Brasile 5
RO - Romania 5
NG - Nigeria 3
NZ - Nuova Zelanda 3
PL - Polonia 3
RU - Federazione Russa 3
AU - Australia 2
EE - Estonia 2
HK - Hong Kong 2
HU - Ungheria 2
JP - Giappone 2
KR - Corea 2
LU - Lussemburgo 2
NO - Norvegia 2
PR - Porto Rico 2
BD - Bangladesh 1
CH - Svizzera 1
CO - Colombia 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
NP - Nepal 1
PT - Portogallo 1
RS - Serbia 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
TW - Taiwan 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 13.018
Città #
Dublin 1.062
Jacksonville 968
Chandler 885
Beijing 440
Dearborn 403
Ashburn 401
Nanjing 336
Ann Arbor 332
Bremen 260
Princeton 259
San Mateo 248
Parma 175
Vienna 149
Izmir 147
Toronto 140
Wilmington 135
Des Moines 118
New York 116
Shenyang 112
Kunming 94
Hebei 93
Hefei 91
Nanchang 86
Shanghai 86
Helsinki 83
Jinan 64
Boardman 58
Woodbridge 58
Grafing 51
Seattle 49
Düsseldorf 45
Changsha 41
Jiaxing 35
Brussels 34
Tianjin 34
Guangzhou 31
Fremont 28
Houston 24
Norwalk 24
Los Angeles 23
Milan 23
Hangzhou 20
Zhengzhou 20
Reggio Nell'emilia 15
Borås 14
Fuzhou 12
Redwood City 12
Singapore 12
Modena 11
Washington 11
Chengdu 10
Haikou 10
Kocaeli 10
Fairfield 9
Falls Church 9
Verona 9
Wuhan 9
Amsterdam 8
Auburn Hills 8
Rome 8
Shaoxing 8
Wenzhou 8
Bilbao 7
Edinburgh 7
Ningbo 7
Pune 7
Redmond 7
Rockville 7
Baotou 6
Cairo 6
Florence 6
London 6
Neviano degli Arduini 6
Scottsdale 6
Taizhou 6
Xian 6
Catania 5
Chongqing 5
Lanzhou 5
Munich 5
Taiyuan 5
Campi Bisenzio 4
Centro 4
Colli Del Tronto 4
Jakarta 4
Lugo 4
Mestre 4
Mountain View 4
Andover 3
Bologna 3
Bordeaux 3
Brampton 3
Buffalo 3
Cambridge 3
Cantagallo 3
Cotonou 3
Esslingen am Neckar 3
Frankfurt am Main 3
Langfang 3
Madrid 3
Totale 8.253
Nome #
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 109
L’antibiogramma per i miceti 107
Antibacterial effects of two synthetic peptides against Enterococcus faecalis biofilms: A preliminary in vitro study 95
Candidacidal activity of a novel killer toxin from Wickerhamomyces anomalus against fluconazole-susceptible and -resistant strains 94
In vitro and in vivo anti-Candida activity and structural analysis of killer peptide (KP)-derivatives 93
Significato diagnostico delle IgA (secretorie) adese a miceti lievitiformi nel corso delle infezioni orali di pazienti a rischio. 92
Peptides of the Constant Region of Antibodies Display Fungicidal Activity 91
Metabolic profiling of Candida albicans 88
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 84
Antifungal peptides within the antibodies 84
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 83
Anti-infective antibody-derived peptides active against endogenous and exogenous fungi 82
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 80
Detection of Mycobacterium bovis in bovine tissue samples by the Abbott LCx Mycobacterium tuberculosis assay and comparison with culture methods 78
Antibodies as a source of anti-infective peptides: an update 78
Antibody-mediated protective immunity in fungal infections 77
Activity of two antimicrobial peptides against Enterococcus faecalis in a model of biofilm-mediated endodontic infection 77
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 75
Antibody peptide based antifungal immunotherapy 74
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 74
ANTIMICROBIAL EFFECT ON CANDIDA ALBICANS BIOFILMS WITH DIFFERENT WAVELENGTHS AND DYES WITH SYNTHETIC KILLER DECAPEPTIDE 74
Antibiocorpi: anticorpi antiidiotipo ad attività antibiotica e profilattica. 73
Production of an engineered killer peptide in Nicotiana benthamiana by using a Potato virus X expression system 72
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 72
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 72
Fungicidal activity of peptides encoded by immunoglobulin genes 72
Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins 72
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation 72
A synthetic peptide as a novel anticryptococcal agent 70
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. 70
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 70
Antibodies as Crypts of Antiinfective and Antitumor Peptides 69
Natural and synthetic peptides with antifungal activity 69
ANTIMICROBIAL EFFECT ON CANDIDA ALBICANS BY DIFFERENT COUPLING OF WAVELENGTHS AND COLORS IN PHOTODYNAMIC PROTOCOLS: IN VITRO AND IN VIVO STUDY 68
Peptides from the inside of the antibodies are active against infectious agents and tumours 68
Anaerobic yeast killer system. 66
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 66
Effect of different wavelengths and dyes on Candida albicans: In vivo study using Galleria mellonella as an experimental model 66
A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities 66
Antibiobodies: antibiotic internal image antibodies 65
Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies. 65
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 65
A peptide found in human serum, derived from the c-terminus of albumin, shows antifungal activity in vitro and in vivo 65
Nuovo modello di vaccinazione idiotipica e terapia anti-idiotipica nella candidosi sistemica 64
Wickerhamomyces yeast killer toxins’ medical applications 64
Therapeutic potential of yeast killer toxin-like antibodies and mimotopes 63
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity 63
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 63
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 63
Metabolic profile of Candida albicans 63
Anticorpi antibiotici antiidiotipo immagini interne di tossine killer. 63
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 63
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 63
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis 62
Immagine interna del fenomeno killer dei lieviti 62
Caratterizzazione di mannoproteine da stress di Candida albicans reattive con IgA secretorie 61
Antireceptor yeast killer toxin-like antibiobodies 61
Marcatori epidemiologici. 61
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 61
Antifungal activity of the C-terminal peptide from human serum albumin 61
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 61
Yeast killer toxins and dimorphism. 60
Principi di micologia generale e tassonomia 59
Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food 59
Antibiobodies: antibiotic-like antiidiotypic antibodies. 59
Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides 58
Valutazione del "Bacto INH Test Strips" per la determinazione della produzione di niacina nei micobatteri. 58
Antimicrobial peptides with antiprotozoal activity: Current state and future perspectives 58
Antimicrobial effect on candida albicans biofilm bapplication of different wavelengths and dyes and the synthetic killer decapeptide KP 58
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 58
Any antibody fragment might exert antifungal activity 58
Antimicrobial peptide L18R displays a modulating action against inter-kingdom biofilms in the Lubbock chronic wound biofilm model 58
Mode of action of a killer peptide against Toxoplasma gondii 58
Mycobacterium parmense sp. nov 57
Protective antifungal yeast killer toxin-like antibodies 57
Engineered commensal bacteria as delivery systems of anti-infective mucosal protectants 57
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis 57
Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. 56
Production of yeast killer toxin in experimentally infected animals 56
From Pichia anomala killer toxin through killer antibodies to killer peptides for a comprehensive anti-infective strategy 56
Restriction of Influenza virus multiplication induced by PK peptide treatment 56
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 56
Vaccine for the prevention of Aflatoxin B1 carry over in the milk of lactating dairy cows 56
Anticorpi immagini interne di tossine killer 56
Innate antimicrobial and antiviral activities of antibody peptides 55
Recombinant Streptococcus gordonii for mucosal delivery of a scFv microbicidal antibody 55
Genomic studies on killer yeasts belonging to the genus Pichia. 55
Candidacidal properties of peptides encoded by immunoglobulin genes 55
In vitro activity of monoclonal and recombinant yeast killer toxin-like antibodies against antibiotic-resistant Gram-positive cocci 54
Detection by immunofluorescent anti-idiotypic antibodies of yeast killer toxin cell wall receptors of Candida albicans. 54
The activity of a mammalian proline-rich peptide against Gram-negative bacteria, including drug-resistant strains, relies on a nonmembranolytic mode of action 54
Automazione dell’antibiogramma diretto sulle urine. 54
Protective immunization against group B meningococci using anti-idiotypic mimics of the capsular polysaccharide 54
"Antibiobodies": yeast killer toxin-like anti-idiotypic antibodies 54
A transphyletic anti-infectious control strategy based on the killer phenomenon. 54
Idiotypic antifungal vaccination: Immunoprotection by antiidiotypic antibiotic antibodies 54
Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria 53
Bacterial biotyping by killer system 53
Biotipizzazione di microorganismi patogeni mediante il sistema killer dei lieviti. 53
Yeast killer toxine-like anti-idiotypic antibodies protecting mice against candidosis 53
Totale 6.609
Categoria #
all - tutte 44.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.513


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019254 0 0 0 0 0 0 0 0 0 0 226 28
2019/20203.174 542 517 210 43 297 295 381 91 246 272 71 209
2020/20211.560 24 212 157 25 241 40 212 22 303 42 226 56
2021/20221.306 31 6 24 59 58 68 169 221 51 128 64 427
2022/20234.045 504 352 216 259 539 456 35 235 1.311 12 92 34
2023/20241.123 79 147 48 55 132 381 59 77 25 90 30 0
Totale 13.201